Emtricitabine, classified under HS code 30049099, is subject to varying tariff rates and exemptions across key importing countries.
South Africa: As a member of the Southern African Customs Union (SACU), South Africa applies a common external tariff to imports. Medicaments under HS code 30049099 are generally subject to a 0% Most Favored Nation (MFN) tariff rate. Additionally, South Africa has an Economic Partnership Agreement (EPA) with the European Union and the United Kingdom, which may influence preferential rates for certain products.
United States: The U.S. Harmonized Tariff Schedule (HTS) lists medicaments under HS code 30049099 as duty-free under the MFN rate. There are no specific preferential rates for Emtricitabine under existing Free Trade Agreements (FTAs) with India.
European Union (France, Poland): The EU's Common External Tariff applies a 0% MFN rate to products under HS code 30049099. While the EU has FTAs with various countries, there is no specific agreement with India that alters this rate for Emtricitabine.
United Kingdom: Post-Brexit, the UK maintains a 0% MFN tariff rate for medicaments under HS code 30049099. The UK has an EPA with South Africa, which may influence trade terms for certain products.
Zimbabwe, Tanzania, Malta: Specific tariff information for these countries is less readily available. However, many countries offer reduced or zero tariffs on essential medicines, especially those listed by the World Health Organization (WHO). It's advisable to consult the respective national customs authorities for precise rates and any applicable exemptions.
